Published in Women's Health Weekly, February 24th, 2011
"The clinical factors studied included stage, age, CA-125, residual tumors, and chemotherapy regimens. Positive p53 immunoexpression was 44.8% (26/58) of OCCAs; in contrast,...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Women's Health Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.